PREVALENCE OF ADMISSIONS FOR HEPATITIS B AND C IN A REFERENCE HOSPITAL IN THE STATE OF PARAÍBA, BRAZIL
Article Sidebar
Main Article Content
Abstract
Viral hepatitis represents an important public health problem due to its disabling potential and the possibility of progression to liver cancer and even death. Among the various types of viral hepatitis, the most common are Hepatitis B and Hepatitis C. The present study aims to investigate the prevalence of hospitalizations for viral hepatitis in a reference hospital in the state of Paraíba during the year 2023. The research was carried out using data from the Alcides Carneiro University Hospital, part of the Empresa Brasileira de Serviços Hospitalares network. Data were collected from the Notifiable Diseases Information System. After calculating the prevalence, it was observed that Hepatitis B and C represent 24% of hospitalizations in the group of compulsory notification diseases. The results indicate the need to intensify primary and secondary prevention actions. Despite the implementation of basic care, viral hepatitis type B being vaccine-preventable and prevention and treatment campaigns promoted by the Ministry of Health, these diseases continue to be an important cause of morbidity and mortality in the epidemiological profile. This suggests the need for greater integration of the health care network and intensification of disease prevention and control strategies.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
ALVES, N. G. et al. “Soroprevalência e fatores de risco das hepatites A, B e C em uma unidade de referência de doenças infecciosas e parasitárias especiais, em Belém, estado do Pará, Brasil”. Rev Pan-Amaz Saude, vol. 13, e202200942, julho, 2022.
BLOCK, P. D.; LIM, J. K. “Chronic Hepatitis B Virus: what an internist needs to know: serologic diagnosis, treatment options, and Hepatitis B virus reactivation”. Med Clin North Am, vol. 107, n. 3, february, 2023.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST). Brasília: 2022. Disponível em: https://www.gov.br/aids/pt-br/centrais-de-conteudo/pcdts/2022/ist/pcdt-ist-2022_isbn-1.pdf/view. Acesso em: 30/01/2023.
BRITO, W. I.; SOUTO, F. J. D. “Vacinação universal contra hepatite A no Brasil: análise da cobertura vacinal e da incidência cinco anos após a implantação do programa”. Rev Bras Epidemiol, vol. 23, julho, 2020.
CHEN, S. et al. “Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China”. BMJ Global Health, vol. 5, n.6, june, 2020.
EVANGELISTA, C. B. A. I. et al. “Aspectos epidemiológicos da hepatite B no município de Teresina”. REAS, vol. 13, n. 5, maio, 2021.
FERRI, L. P. et al. “Viral hepatitis a, B and C in a Group of Transgender Women in Central Brazil”. Tropical Medicine and Infectious Disease, vol. 7, n. 10, september, 2022.
GOMES, A. M. et al. “Hepatites virais: uma análise clínico-epidemiológica no estado do Tocantins nos últimos 18 anos”. Rev Tocantins, vol. 7, n. 2, 2020.
GUIMARÃES, L. C. C. et al. “Epidemiology of hepatitis B virus infection in people living in poverty in the central west region of Brazil”. BMC Public Health, vol. 19, n. 01, april, 2019.
JIAO, L. et al. “The spatial-temporal distribution of hepatitis B virus infection in China, 2006–2018”. BMC Infectious Diseases, vol. 24, n. 1, august, 2024.
JINDAL, N.; GOYAL, L. D.; SINGH, C. “Sociodemographic features associated with Hepatitis C Virus (HCV) in pregnant females: a tertiary care centre study from Malwa region of Punjab (North India)”. J Family Med Prim Care, vol. 10, n. 7, july, 2021.
LI, F. D. “Epidemiological characteristics and time series analysis of notifiable infectious diseases in Ruili City, 2012–2021”. Master’s Thesis.Jilin University, 2023.
MANGALA, C. et al. “Prevalence and factors associated with transfusion-transmissible infections (HIV, HBV, HCV and Syphilis) among blood donors in Gabon: Systematic review and meta-analysis”. PloS one, vol. 19, n. 8, august, 2024.
MARQUES, J. V. S. et al. “Análise sociodemográfica das hepatites virais no estado do Ceará”. SANARE, vol. 18, n. 2, maio, 2019.
NUNES L. Panorama da Cobertura Vacinal no Brasil 2020. Instituto de Estudos para Políticas de Saúde. Relatórios do IEPS. 2021. Disponível em: https://ieps.org.br/wp-content/uploads/2021/05/Panorama_IEPS_01.pdf. Acesso em: 28/02/2023.
PORTELLA, T. P.; KRAENKEL, R. A. “Spatial-temporal pattern of cutaneous leishmaniasis in Brazil”. Infectious Diseases of Poverty, vol. 10, n. 03, june, 2021.
QU, L. et al. “The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial study”. BMC Infectious Diseases, vol. 21, september, 2021.
ROQUAYROL, LMZ. Epidemiologia e Saúde. São Paulo: Medboock, 2018.
SANTOS, D. A. S. et al. “Trend of viral hepatitis cases notified in the state of Mato Grosso – Brazil”. Cogitare Enferm, vol. 28, august, 2023.
SHI, Y. et al. “Analysis of the spatial-temporal distribution characteristics of hepatitis E in Jiangsu province from 2005 to 2020”. Frontiers in Public Health, vol. 11, august, 2023.
TIMOTEO, M. V. F. et al. “Perfil epidemiológico das hepatites virais no Brasil”. RSD, vol. 9, n. 6, april, 2020.
WANG, Y. et al. “Spatio-temporal distribution characteristics of the risk of viral hepatitis B incidence based on INLA in 14 prefectures of Xinjiang from 2004 to 2019”. Mathematical Biosciences and Engineering, vol. 20, n. 6, april, 2023.
WEINHEIMER‐HAUS, E. M. et al. “Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan”. Journal of Viral Hepatitis, v. 28, n. 2, 2021.
WEIS-TORRES, S. M. S. et al. “High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: a challenge for vaccination coverage”. Int J Infect Dis, vol. 90, january, 2020.
WORLD HEALTH ORGANIZATION (WHO). Criteria for validation of elimination of viral hepatitis B and C: report of seven country pilots. [Internet] Geneva: World Health Organization; 2022. Disponível em: https://apps.who.int/iris/rest/bitstreams/1462490/retrieve. Acesso em: 31/01/2023.
YANG, S. et al. “Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?”. Emerging microbes & infections, vol. 10, n. 1, august, 2021.